BackNos services

Notre réputation de banque d’affaires internationale s’est construite sur une proposition d’accompagnement sur-mesure combinée à de fortes spécialisations sectorielles.

BackNos secteurs

Nous avons placé au cœur de notre démarche d’accompagnement le partage de nos connaissances sectorielles et de nos analyses de marché, afin de permettre à nos clients d’atteindre leurs objectifs.

Clearwater International Germany advises CoGAP on the sale of the majority of shares to R-Biopharm

Clearwater International Germany has advised the shareholders of CoGAP GmbH (CoGAP) on the sale of the majority of shares to R-Biopharm AG (R-Biopharm).

Founded in 2009, CoGAP is a highly innovative company specialised in genetic analysis for health optimisation. The company evaluates the latest discoveries within human genetics, and incorporates these into practical applications. CoGAP allows its customers to tailor their health care to their specific needs, and to select the optimal health care recommendations from the breadth of available health care advice.

Headquarted in Germany, R-Biopharm is a leading developer of test solutions for clinical diagnostics, plus food and feed analysis. In both sectors, the R-Biopharm test kits offer high precision and accuracy, key requirements when patient and consumer health is at risk.

    Image of CoGAP GmbH Company Logo
    a cédé une participation majoritaire à
    Image of R-Biopharm AG Company Logo
    Sell-side
    Non divulgué
    View Back of Transaction
    Equipe Clearwater

    Conseil de CoGAP GmbH dans la cession d'une participation majoritaire à R-Biopharm AG

    En savoir plus

Equipe Clearwater

Retour aux transactions
Scroll to Top